Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Bristol Laboratories Ltd., Unit 3, Canalside, Northbridge Road, Berkhamsted, Herts, HP4 1EG, United Kingdom
Hydroxychloroquine Sulfate 200 mg Film–Coated Tablets.
Quinoric 200mg Film-Coated Tablets.
| Pharmaceutical Form |
|---|
|
Film coated tablet (tablet). White, circular, biconvex film coated tablets embossed with ‘BL’ on one face and ‘200’ on the other. |
Each film-coated tablet contains 200 mg Hydroxychloroquine Sulfate B.P.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Hydroxychloroquine |
Hydroxychloroquine is a antimalarial agent with have several pharmacological actions which may be involved in their therapeutic effect in the treatment of rheumatic disease, but its role is not known. |
| List of Excipients |
|---|
|
Maize starch |
Al/PVC blister, pack sizes of 30, 60 and 100 tablets.
Not all pack sizes may be marketed.
Bristol Laboratories Ltd., Unit 3, Canalside, Northbridge Road, Berkhamsted, Herts, HP4 1EG, United Kingdom
PL 17907/0017
Date of First Authorisation: 15th February 2007
Date of Renewal of Authorisation: 12th October 2011
| Drug | Countries | |
|---|---|---|
| QUINORIC | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
